Pien Huang
Pien Huang is a health reporter on the Science desk. She was NPR's first Reflect America Fellow, working with shows, desks and podcasts to bring more diverse voices to air and online.
She's a former producer for WBUR/NPR's On Point and was a 2018 Environmental Reporting Fellow with The GroundTruth Project at WCAI in Cape Cod, covering the human impact on climate change. As a freelance audio and digital reporter, Huang's stories on the environment, arts and culture have been featured on NPR, the BBC and PRI's The World.
Huang's experiences span categories and continents. She was executive producer of Data Made to Matter, a podcast from the MIT Sloan School of Management, and was also an adjunct instructor in podcasting and audio journalism at Northeastern University. She worked as a project manager for public artist Ralph Helmick to help plan and execute The Founder's Memorial in Abu Dhabi and with Stoltze Design to tell visual stories through graphic design. Huang has traveled with scientists looking for signs of environmental change in Cameroon's frogs, in Panama's plants and in the ocean water off the ice edge of Antarctica. She has a degree in environmental science and public policy from Harvard.
-
A pause in the distribution of the Johnson & Johnson vaccine will last at least another week, even as eligibility for coronavirus vaccines expand. What impact will the pause have on inoculations?
-
The CDC's independent vaccine advisory group is reviewing the safety of the Johnson & Johnson COVID-19 vaccine. The government recommended a pause in administering the vaccine during the review.
-
The pause of administering the Johnson & Johnson vaccine could affect the rollout of COVID-19 vaccines in the U.S., especially since it's so practical for rural areas.
-
A year into the pandemic, the agency's staffers reflect on what it's been like to fight the biggest public health battle in their history and how they're working to rebuild public trust in science.
-
The process to sign up for COVID-19 vaccines varies by place so NPR created a tool to help you understand how things work in your state and connect you with local resources.
-
With vaccine still scarce, and eligibility differing from place to place, some people have easier access to "extra" doses than others. Careful, ethicists warn. Going out of turn is a slippery slope.
-
What does it mean for the Johnson and Johnson vaccine to be 66% effective, compared with the 95% efficacy of the Moderna or Pfizer vaccines? We break down the numbers.
-
President Biden's goal is 100 million COVID-19 vaccine doses in 100 days. Health experts say it sounds ambitious, but it is within reach.
-
Any air passengers flying to the U.S. will have to test negative for COVID-19. The CDC policy takes effect later this month and require passengers to get tested within 3 days of their flight.
-
The United States is now a few weeks into a massive COVID-19 vaccination campaign. And it has been going slower than health officials had hoped. NPR looks at solutions for speeding it up.
-
A third of Black Americans are hesitant to get a COVID-19 vaccine, according to a Kaiser Family Foundation poll. Some Black doctors are finding creative ways to encourage vaccine acceptance.
-
That number may sound like a lot but it's short of the original goal. As the second week of vaccinations draws to an end, officials say there are "some hiccups," but things are going more smoothly.